CYTK vs BBIO
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 01, 2026
CYTK
BBIO
Investment Advisor Scores
BBIO
Oct 01, 2026AI Analyst Insights
Detailed Metrics Comparison
| Metric | CYTK | BBIO | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 117.6471 | 0 | Tie |
| PEG Ratio | -0.42 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -57.1% | 120.4% | BBIO |
| Earnings Growth | 0.0% | 0.0% | Tie |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 68.0/100 | 74.8/100 | BBIO |
| Profit Margin | 0.0% | -97.0% | CYTK |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
| Implied Volatility | N/A | N/A | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CYTK
MarkdownPrice below a falling SMA50 (slope -7.0%), weak momentum, RSI 34
BBIO
MarkdownPrice below a falling SMA50 (slope -4.7%), weak momentum, RSI 35
Fundamentals Snapshot
| Metric | CYTK | BBIO |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -14.7 | 2433.1 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.6% | 1.2% |
| Gross Margin | -5.0% | 0.9% |
| Operating Margin | -6.3% | -0.4% |
| EPS | -7.25 | -3.56 |
| Dividend Yield | — | — |